These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14639347)

  • 1. The role of poxviruses in tumor immunotherapy.
    Kaufman HL
    Surgery; 2003 Nov; 134(5):731-7. PubMed ID: 14639347
    [No Abstract]   [Full Text] [Related]  

  • 2. Poxviruses as vectors for cancer immunotherapy.
    Kwak H; Hörig H; Kaufman HL
    Curr Opin Drug Discov Devel; 2003 Mar; 6(2):161-8. PubMed ID: 12669450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
    Hwang C; Sanda MG
    Curr Opin Mol Ther; 1999 Aug; 1(4):471-9. PubMed ID: 11713762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poxvirus cancer therapy.
    Gilbert PA; McFadden G
    Recent Pat Antiinfect Drug Discov; 2006 Nov; 1(3):309-21. PubMed ID: 18221156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapeutic strategies for cancer using poxvirus vectors.
    Paoletti E; Tartaglia J; Cox WI
    Ann N Y Acad Sci; 1993 Aug; 690():292-300. PubMed ID: 8368744
    [No Abstract]   [Full Text] [Related]  

  • 6. Poxvirus vaccines for cancer and HIV therapy.
    Essajee S; Kaufman HL
    Expert Opin Biol Ther; 2004 Apr; 4(4):575-88. PubMed ID: 15102606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing immunotherapy as legitimate therapy for patients with prostate cancer.
    Small EJ; Fong L
    J Clin Oncol; 2010 Mar; 28(7):1085-7. PubMed ID: 20100956
    [No Abstract]   [Full Text] [Related]  

  • 8. Rekindling cancer vaccines.
    Branca MA
    Nat Biotechnol; 2016 Oct; 34(10):1019-1024. PubMed ID: 27727216
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer immunotherapy using recombinant Listeria monocytogenes: transition from bench to clinic.
    Singh R; Wallecha A
    Hum Vaccin; 2011 May; 7(5):497-505. PubMed ID: 21422819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy with poxvirus vectors.
    Moroziewicz D; Kaufman HL
    Curr Opin Mol Ther; 2005 Aug; 7(4):317-25. PubMed ID: 16121697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant viruses as a tool for therapeutic vaccination against human cancers.
    Bonnet MC; Tartaglia J; Verdier F; Kourilsky P; Lindberg A; Klein M; Moingeon P
    Immunol Lett; 2000 Sep; 74(1):11-25. PubMed ID: 10996623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel recombinant alphaviral and adenoviral vectors for cancer immunotherapy.
    Osada T; Morse MA; Hobeika A; Lyerly HK
    Semin Oncol; 2012 Jun; 39(3):305-10. PubMed ID: 22595053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costimulatory molecules in vaccine design.
    Hodge JW; Schlom J
    Ernst Schering Res Found Workshop; 2000; (30):23-52. PubMed ID: 10943315
    [No Abstract]   [Full Text] [Related]  

  • 14. Mutation-Derived Tumor Antigens: Novel Targets in Cancer Immunotherapy.
    Finnigan JP; Rubinsteyn A; Hammerbacher J; Bhardwaj N
    Oncology (Williston Park); 2015 Dec; 29(12):970-2, 974-5. PubMed ID: 26676902
    [No Abstract]   [Full Text] [Related]  

  • 15. Poxviruses as vectors for veterinary vaccines.
    Boyle DB
    Aust Vet J; 1989 Dec; 66(12):419-20. PubMed ID: 2695041
    [No Abstract]   [Full Text] [Related]  

  • 16. Poxviral vectors for cancer immunotherapy.
    Kim JW; Gulley JL
    Expert Opin Biol Ther; 2012 Apr; 12(4):463-78. PubMed ID: 22413824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials.
    Mossoba ME; Medin JA
    Expert Rev Vaccines; 2006 Oct; 5(5):717-32. PubMed ID: 17181444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing cancer immunotherapy trials: back to basics.
    Stevenson FK; Rice J
    Eur J Immunol; 2006 May; 36(5):1070-3. PubMed ID: 16639707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer immunotherapy: phase II clinical studies with TG4010 (MVA-MUC1-IL2).
    Acres B
    J BUON; 2007 Sep; 12 Suppl 1():S71-5. PubMed ID: 17935281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new era for cancer immunotherapy based on the genes that encode cancer antigens.
    Rosenberg SA
    Immunity; 1999 Mar; 10(3):281-7. PubMed ID: 10204484
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.